3,4-dihydroxybenzohydroxamic acid has been researched along with su 11248 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enokida, H; Nakagawa, M; Osako, Y; Sakaguchi, T; Sugita, S; Yonemori, M; Yoshino, H | 1 |
1 other study(ies) available for 3,4-dihydroxybenzohydroxamic acid and su 11248
| Article | Year |
|---|---|
Potential tumor‑suppressive role of microRNA‑99a‑3p in sunitinib‑resistant renal cell carcinoma cells through the regulation of RRM2.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Kidney Neoplasms; Male; MicroRNAs; Middle Aged; Ribonucleoside Diphosphate Reductase; Sunitinib | 2019 |